Body composition changes associated with second-generation antipsychotic treatment of children and adolescents

被引：0
|
作者：
Correll, CU
Parikh, UH
Parikh, UH
Mughal, T
Olshanskiy, V
Moroff, M
Pleak, RR
Foley, C
Shah, M
Gutkovich, Z
Kane, JM
Malhotra, AK
机构：
[1] Zucker Hillside Hosp, Glen Oaks, NY USA
[2] Schneider Childrens Hosp, New Hyde Pk, NY USA
来源：
BIOLOGICAL PSYCHIATRY | 2005年 / 57卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
124
引用
收藏
页码：36S / 36S
页数：1
相关论文
共 50 条
  • [41] Asenapine: A Clinical Review of a Second-Generation Antipsychotic
    Stoner, Steven C.
    Pace, Heather A.
    CLINICAL THERAPEUTICS, 2012, 34 (05) : 1023 - 1040
  • [42] Dosing equivalency of second-generation antipsychotic medications
    Buckley, PF
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (05) : 501 - 502
  • [43] The Use of Second-Generation Antipsychotics and the Changes in Physical Growth in Children and Adolescents with Perinatally Acquired HIV
    Kapetanovic, Suad
    Aaron, Lisa
    Montepiedra, Grace
    Sirois, Patricia A.
    Oleske, James M.
    Malee, Kathleen
    Pearson, Deborah A.
    Nichols, Sharon L.
    Garvie, Patricia A.
    Farley, John
    Nozyce, Molly L.
    Mintz, Mark
    Williams, Paige L.
    AIDS PATIENT CARE AND STDS, 2009, 23 (11) : 939 - 947
  • [44] Differential characteristics of the efficacy and tolerability of second-generation antipsychotics in the treatment of psychotic disorders in children and adolescents
    Fraguas, David
    Merchan-Naranjo, Jessica
    Arango, Celso
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2010, 3 (04): : 152 - 167
  • [45] Weight Gain Effects of Second-Generation Antipsychotic Treatment in Autism Spectrum Disorder
    Yoon, Yesie
    Wink, Logan K.
    Pedapati, Ernest V.
    Horn, Paul S.
    Erickson, Craig A.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (09) : 822 - 827
  • [46] Time to discontinuation of first- and second-generation antipsychotic medications in the treatment of schizophrenia
    Kreyenbuhl, Julie
    Slade, Eric P.
    Medoff, Deborah R.
    Brown, Clayton H.
    Ehrenreich, Benjamin
    Afful, Joseph
    Dixon, Lisa B.
    SCHIZOPHRENIA RESEARCH, 2011, 131 (1-3) : 127 - 132
  • [47] Risk for adverse health outcome in antipsychotic-naive adolescents after 12 months of treatment with second-generation antipsychotics
    Pina-Camacho, L.
    Merchan-Naranjo, J.
    Garcia-Amador, M.
    Fraguas, D.
    Tapia, C.
    Moreno, C.
    Llorente, C.
    Arango, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S61 - S62
  • [48] Second generation antipsychotic-induced insulin resistance in antipsychotic-naive children and adolescents
    Correll, CU
    Parikh, UH
    Kane, JM
    Malhotra, AK
    BIOLOGICAL PSYCHIATRY, 2004, 55 : 16S - 17S
  • [49] Body Composition Changes Associated With A Structured Exercise Program Among Children And Adolescents
    Peart, Ashley
    Suire, Kameron
    Venezia, Ali
    Winkler, Darby
    Wadsworth, Danielle
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2019, 51 (06): : 523 - 523
  • [50] Incident diabetes associated with use of second-generation antipsychotic (SGA) therapy: An evaluation of the impact of dose and treatment indication
    Harrington, P
    Barner, JC
    Crismon, ML
    Lawson, KA
    Mascarenas, C
    Rascati, KL
    VALUE IN HEALTH, 2006, 9 (03) : A65 - A65
12345